Helping Poorer Patients Pay for Prostate Cancer Meds Keeps Them on Treatment
MONDAY, March 25, 2024 (HealthDay News) — Men with prostate cancer treated at hospitals participating in a special drug-pricing program were more likely to stick to their therapy than patients elsewhere, new research reveals. The federal 340B Drug Program requires the pharmaceutical industry to discount drugs sold to participating hospitalsContinue Reading